Top Markets
Coin of the day
Redx Pharma Plc Redx Pharma Plc

Redx Pharma Plc

REDX
Clasificación en acciones #38811
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
Precio por acción
$0.20410523
Última sincronización: 2024-04-30
Capitalización bursátil
$793.94K
Cambio (1 día)
42.54%
Cambio (1 año)
0.00%
País
GB
Comercio Redx Pharma Plc (REDX)

Categoría

Historial del precio de la acción de Redx Pharma Plc (REDX)
Precio más alto de cierre: $0.12 el 2024-04-01

Precio más bajo de cierre: $1.26 el 2015-03-01
Historial del precio de la acción de Redx Pharma Plc desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -59.88%
2023 -59.57%
2022 -25.78%
2021 29.62%
2020 711.52%
2019 9.53%
2018 -70.73%
2017 -45.20%
2016 -51.74%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$507.52 30.03%
US
$847.62 29.92%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE